Similar articles

• [Evaluation of postoperative immunotherapy of gastric cancer].

  Ochiai T, Sato H. Ochiai T, et al. Gan To Kagaku Ryoho. 1983 Feb;10(2 Pt 2):373-9. Gan To Kagaku Ryoho. 1983. PMID: 6349536 Clinical Trial. Japanese.
• [Treatment of advanced primary lung cancer, particularly immunotherapy with BCG-CWS (author's transl)].

  Ohta M, Iida A, Ueda H, Yasumoto K, Manabe H. Ohta M, et al. Kyobu Geka. 1977 Jul;30(7):581-5. Kyobu Geka. 1977. PMID: 904107 Japanese. No abstract available.
• [Immunotherapy of cancer with BCG].

  Yamamura Y, Azuma I. Yamamura Y, et al. Nihon Rinsho. 1974 Mar;32(3):542-53. Nihon Rinsho. 1974. PMID: 4603604 Review. Japanese. No abstract available.
• [Possible applications of living BCG and the BCG cell wall in immunotherapy].

  Canti GF, Franco P, Ricci L. Canti GF, et al. Boll Ist Sieroter Milan. 1983 May 31;62(2):125-9. Boll Ist Sieroter Milan. 1983. PMID: 6626318 Italian.
• MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.

  Yuan S, Shi C, Liu L, Han W. Yuan S, et al. Expert Opin Biol Ther. 2010 Jul;10(7):1037-48. doi: 10.1517/14712598.2010.485185. Expert Opin Biol Ther. 2010. PMID: 20420512 Review.